Table 3.

Edoxaban treatment status

Total	N = 11 107
Ongoing treatment with edoxaban a	8783 (79.1)
Completion or discontinuation of treatment with edoxaban	2324 (20.9)

Reasons for completion or discontinuation of treatment with edoxaban b
Failure to visit the hospital or transfer to a different hospital	826 (7.4)
Occurrence of clinical events or AEs	741 (6.7)
Treatment completed as planned	350 (3.2)
Switch to other drugs	335 (3.0)
Plan to receive nonpharmacological therapy for AF	30 (0.3)
Plan to receive an invasive procedure (including minor surgery)	25 (0.2)

Data are presented as number (%) unless otherwise indicated.

Abbreviations: AE, adverse events; AF, atrial fibrillation.

^aIncluding interruption during one‐year follow‐up

^bSome overlap present.